TABLE 3.

Preoperative and postoperative characteristics of patients without symptom improvement who experienced disease recurrence

Pt #	Age (y)	Sex	Type of tumor	Genetic syndrome	Type of resection	Size (cm)	Tumor location	R0/R1	Multifocal recurrence	Region of recurrence
1	59	F	VIPoma	None	Anatomic	1.7	Liver	R0	Yes	Distant
2	70	M	VIPoma	None	Anatomic	2	Pancreas	R0	No	Distant
3	47	M	Gastrinoma	Other	Anatomic	9.1	Pancreas	R0	Yes	Distant
4	52	F	Gastrinoma	None	Anatomic	1.3	Pancreas	R0	Yes	–
5	33	M	Gastrinoma	MEN-1	Anatomic	11.5	Pancreas	R0	Yes	Distant
6	45	F	Glucagonoma	None	Anatomic	15.2	Pancreas	R0	Yes	Locoregional + distant
7	52	F	Insulinoma	MEN-1	Anatomic	2.0	Pancreas	R0	No	Locoregional
8	38	M	Insulinoma	None	Anatomic	4.6	Pancreas	R0	No	Distant
9	63	M	Insulinoma	None	Anatomic	12.9	Pancreas	R0	No	Locoregional + distant
10	66	F	Gastrinoma	None	Enucleation	1.8	Pancreas	R1	Yes	Locoregional
11	48	M	Gastrinoma	MEN-1	Enucleation	2.0	Pancreas	R1	–	Locoregional
12	44	F	Gastrinoma	None	Enucleation	1.3	Duodenum	R0	Yes	Locoregional
13	73	F	Gastrinoma	None	Enucleation	5.5	Pancreas	R0	No	Distant
14	38	F	Gastrinoma	MEN-1	Enucleation	1.4	Duodenum	–	Yes	Locoregional
15	42	M	Glucagonoma	None	Enucleation	7.5	Pancreas	R0	No	Distant
16	39	F	Insulinoma	None	Enucleation	1.0	Pancreas	R0	No	Distant
17	91	F	Insulinoma	None	Enucleation	7.5	Pancreas	R0	Yes	Distant

Abbreviation: MEN-I, multiple endocrine neoplasia type 1.